https://www.selleckchem.com/products/gdc-0068.html
There was no significant difference in clinical data and surgical results between the conventional indication group and the risky gland group. Thirty-day major morbidity and mortality was 9.4% and 0%, respectively. Ninety-day mortality rate was 1.4% (n=1, conventional group), with the median follow-up length of 21.5 months. Overall 5-year survival rate was 67.7% for the total participants 87.5% for the risk gland group and 57.9% for the conventional group. There was no significant difference in between the two groups. Total pancreatect
Kao
Komentar
Udio
